Eruptive basal cell carcinoma and lenalidomide: rising awareness among dermatologists

Lenalidomide (L) is approved for treating multiple myeloma (MM), being preferred to its parent drug, thalidomide, for its superior safety. We report the case of a patient developing more than 10 basal cell carcinomas (BCCs) within 1 month of starting L. Notably, his treating hematologist neither rec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Calogero Pagliarello (Autor), Carlo Renè Girardelli (Autor), Ignazio Stanganelli (Autor)
Format: Llibre
Publicat: PAGEPress Publications, 2022-07-01T00:00:00Z.
Matèries:
Accés en línia:Connect to this object online.
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

Connect to this object online.

3rd Floor Main Library

Detall dels fons de 3rd Floor Main Library
Signatura: A1234.567
Còpia 1 Disponible